These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5561446)

  • 1. [Synthesis and activity of substituted 5-aryl-2-pyrrolidinones(DL)].
    Bocchi V; Gardini GP; Pinza M
    Farmaco Sci; 1971 May; 26(5):429-34. PubMed ID: 5561446
    [No Abstract]   [Full Text] [Related]  

  • 2. A new class of pyrrolidin-2-ones: synthesis and pharmacological study.
    Saturnino C; Capasso A; Saturnino P; De Martino G; Sorrentino L; Lancelot JC; Robba M
    J Pharm Belg; 1997; 52(2):57-60. PubMed ID: 9193130
    [No Abstract]   [Full Text] [Related]  

  • 3. Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: synthesis and biological evaluation.
    Micheli F; Pasquarello A; Tedesco G; Hamprecht D; Bonanomi G; Checchia A; Jaxa-Chamiec A; Damiani F; Davalli S; Donati D; Gallotti C; Petrone M; Rinaldi M; Riley G; Terreni S; Wood M
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3906-12. PubMed ID: 16730983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy.
    Pollard JR
    Curr Opin Investig Drugs; 2008 Jan; 9(1):101-7. PubMed ID: 18183537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and biological activity of 1,5-diaryl-3-alkylamino-4-carboxymethyl-2,5-dihydropyrrol-2-ones and 1,5-diaryl-4-carboxymethyltetrahydropyrrol-2,3-diones].
    Gein VL; Popov AV; Kolla WE; Popova NA
    Pharmazie; 1993 Feb; 48(2):107-9. PubMed ID: 8475156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones.
    Peukert S; Sun Y; Zhang R; Hurley B; Sabio M; Shen X; Gray C; Dzink-Fox J; Tao J; Cebula R; Wattanasin S
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1840-4. PubMed ID: 18295483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological properties of some 2-pyrrolidinone Mannich bases.
    Malawska B; Gorczyca M; Chojnacka-Wójcik E; Tatarczyńska E
    Pol J Pharmacol Pharm; 1982; 34(5-6):373-82. PubMed ID: 6985304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pyrrolidine-2,5-diones with basic substituents. 3. Anticonvulsant activity of racemic and optically active pyrrolidine-2,5-diones].
    Knabe J; Büch HP; Konrad H
    Arch Pharm (Weinheim); 1986 Apr; 319(4):296-302. PubMed ID: 3718182
    [No Abstract]   [Full Text] [Related]  

  • 10. 3,3-Dialkyl- and 3-alkyl-3-benzyl-substituted 2-pyrrolidinones: a new class of anticonvulsant agents.
    Reddy PA; Hsiang BC; Latifi TN; Hill MW; Woodward KE; Rothman SM; Ferrendelli JA; Covey DF
    J Med Chem; 1996 Apr; 39(9):1898-906. PubMed ID: 8627613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactions with anthranilamides. V. Synthesis of 1,2,3,4-tetrahydro-2-spiro-(2'-tetrahydrofurano) quinazoline-3-substituted and of 2-(N-pyrrolidin-2-on) aminobenzamides].
    Landi Vittory R; Gatta F
    Farmaco Sci; 1972 Mar; 27(3):208-16. PubMed ID: 5022160
    [No Abstract]   [Full Text] [Related]  

  • 12. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones.
    Kamiński K; Obniska J
    Bioorg Med Chem; 2008 May; 16(9):4921-31. PubMed ID: 18375131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total synthesis of the duocarmycins.
    Yamada K; Kurokawa T; Tokuyama H; Fukuyama T
    J Am Chem Soc; 2003 Jun; 125(22):6630-1. PubMed ID: 12769562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous-flow protocol for the synthesis of enantiomerically pure intermediates of anti epilepsy and anti tuberculosis active pharmaceutical ingredients.
    Aguiar RM; Leão RAC; Mata A; Cantillo D; Kappe CO; Miranda LSM; de Souza ROMA
    Org Biomol Chem; 2019 Feb; 17(6):1552-1557. PubMed ID: 30693360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of tetramic and tetronic acids as beta-secretase inhibitors.
    Larbig G; Schmidt B
    J Comb Chem; 2006; 8(4):480-90. PubMed ID: 16827559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Chemoenzymatic Synthesis of the Chiral Key Intermediate of the Antiepileptic Brivaracetam.
    Ciceri S; Grisenti P; Reza Elahi S; Ferraboschi P
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactions of 5-aryl-furan-2,3-diones with acylmethylenetriphenylphosphoranes: synthesis and biological activity of 3(2H)-furanone derivatives.
    Kozminykh VO; Igidov NM; Kozminykh EN; Aliev ZG
    Pharmazie; 1993 Feb; 48(2):99-106. PubMed ID: 8475167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one.
    Coutrot P; Claudel S; Didierjean C; Grison C
    Bioorg Med Chem Lett; 2006 Jan; 16(2):417-20. PubMed ID: 16271473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GABA-GABOB analogues. III - Synthesis and biochemical activity of new alkyl and acyl derivatives of 4-hydroxy-2-pyrrolidinone.
    Pellegata R; Pinza M; Pifferi G; Gaiti A; Mozzi R; Tirillini B; Porcellati G
    Farmaco Sci; 1981 Oct; 36(10):845-55. PubMed ID: 7308456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of some N-substituted 3,4-pyrroledicarboximides as potential CNS depressive agents.
    Malinka W; Sieklucka-Dziuba M; Rajtar G; Rejdak R; Rejdak K; Kleinrok Z
    Pharmazie; 2000 Jan; 55(1):9-16. PubMed ID: 10683864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.